Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab Research Letter

  

Authors:	Stuver, R.; Vardhana, S. A.; Bedmutha, A.; Chan, K. K.; Mirtcheva-Trocheva, R.; Nosov, A.; Schöder, H.; Moskowitz, A.
Title:	Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab
Keywords:	adult; cancer chemotherapy; clinical article; treatment response; prednisone; allogeneic stem cell transplantation; case report; cancer growth; drug withdrawal; gemcitabine; cancer patient; methotrexate; positron emission tomography; letter; autologous stem cell transplantation; pathology; vinblastine; hodgkin disease; monoclonal antibody; drug antagonism; immune response; lymphoma, non-hodgkin; lactate dehydrogenase; rheumatoid arthritis; corticosteroid; disease control; leukocytosis; everolimus; leukocyte; lymphadenopathy; night sweat; non-hodgkin lymphoma; classical hodgkin lymphoma; adalimumab; tocilizumab; antibodies, monoclonal, humanized; brentuximab vedotin; humans; human; male; pembrolizumab; positron emission tomography-computed tomography
Journal Title:	Leukemia and Lymphoma
Volume:	64
Issue:	14
ISSN:	1042-8194
Publisher:	Taylor & Francis Group
Date Published:	2023-01-01
Start Page:	2351
End Page:	2353
Language:	English
DOI:	10.1080/10428194.2023.2262641
PUBMED:	37794809
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85173429456&doi=10.1080%2f10428194.2023.2262641&partnerID=40&md5=afcc4cf9e6aa27e7b37d7c30db3d5d45
Notes:	Letter -- MSK corresponding author is Robert Stuver -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/213237